Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.docVIP

Available online /content/7/3/R439 Research article Open Access Vol 7 No 3 Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab Xenofon Baraliakos1, Joachim Listing2, Jan Brandt1, Martin Rudwaleit3, Joachim Sieper3 and Juergen Braun1 1Rheumazentrum Ruhrgebiet, Herne, Germany 2German Rheumatism Research Center, Berlin, Germany 3Charité, Medical University of Berlin, Campus Benjamin Franklin, Department of Rheumatology, Germany Corresponding author: Juergen Braun, j.braun@rheumazentrum-ruhrgeb